|
Michael T. McCaul
|
house |
JPMorgan Chase Corp |
JPM |
STOCK |
PURCHASE
|
Feb. 21, 2017 |
$$100,001-250,000 |
March 17, 2017 |
|
Michael T. McCaul
|
house |
JPMORGAN CHASE & CO |
JPM |
STOCK |
PURCHASE
|
Feb. 20, 2017 |
$$50,001-100,000 |
March 17, 2017 |
|
Francis Rooney
|
house |
Philip Morris International, Inc. |
PM |
STOCK |
PURCHASE
|
Feb. 17, 2017 |
$$1,000-15,000 |
Feb. 17, 2017 |
|
Francis Rooney
|
house |
JP Morgan Corp. |
JPM |
STOCK |
PURCHASE
|
Feb. 17, 2017 |
$$1,000-15,000 |
Feb. 17, 2017 |
|
Charlie Joseph Crist
|
house |
JP Morgan Chase & Co. (JPM) |
JPM |
STOCK |
nan
|
Feb. 10, 2017 |
$$1,001 - $15,000 |
March 6, 2017 |
|
James B. Renacci
|
house |
PHILIP MORRIS INTERNATIONAL INCORPORATED |
PM |
STOCK |
PURCHASE
|
Feb. 8, 2017 |
$$15,001 - $50,000 |
Feb. 22, 2017 |
|
Bill Flores
|
house |
Philip Morris International Inc (PM) |
PM |
STOCK |
nan
|
Feb. 3, 2017 |
$$1,001 - $15,000 |
March 8, 2017 |
|
Michael T. McCaul
|
house |
J P MORGAN CHASE & CO |
JPM |
STOCK |
PURCHASE
|
Feb. 1, 2017 |
$$1,000-$15,000 |
March 17, 2017 |
|
Michael T. McCaul
|
house |
J P MORGAN CHASE & CO |
JPM |
STOCK |
PURCHASE
|
Feb. 1, 2017 |
$$15,001-$50,000 |
March 17, 2017 |
|
K. Michael Conaway
|
house |
Philip Morris International Inc (PM) |
PM |
STOCK |
Purchase
|
Jan. 18, 2017 |
$$1,001 - $15,000 |
Feb. 6, 2017 |
|
K. Michael Conaway
|
house |
JP Morgan Chase & Co. (JPM) |
JPM |
STOCK |
Sale
|
Jan. 18, 2017 |
$$1,001 - $15,000 |
Feb. 6, 2017 |
|
Lois Frankel
|
house |
JP Morgan Chase & Co. (JPM) |
JPM |
STOCK |
Sale
|
Jan. 11, 2017 |
$$1,001 - $15,000 |
Jan. 19, 2017 |
|
John B. Larson
|
house |
JP Morgan Chase & CO |
JPM |
STOCK |
Purchase
|
Jan. 11, 2017 |
$$15,001-$50,000 |
Jan. 31, 2017 |
|
Thomas MacArthur
|
house |
Astellas Pharma Inc Unsponsored ADR (ALPMY) |
ALPMY |
STOCK |
Purchase
|
Jan. 10, 2017 |
$$1,001 - $15,000 |
Feb. 8, 2017 |
|
Thomas MacArthur
|
house |
Astellas Pharma Inc Unsponsored ADR (ALPMY) |
ALPMY |
STOCK |
Purchase
|
Jan. 9, 2017 |
$$15,001 - $50,000 |
Feb. 8, 2017 |
|
Pete Sessions
|
house |
JP Morgan Chase & Co. (JPM) |
JPM |
STOCK |
P
|
Jan. 4, 2017 |
$$15,001 - $50,000 |
Jan. 23, 2017 |
|
Rubén Hinojosa
|
house |
JP Morgan Chase & Co. (JPM) |
JPM |
STOCK |
Purchase
|
Dec. 27, 2016 |
$$1,001 - $15,000 |
Jan. 29, 2017 |
|
Rubén Hinojosa
|
house |
JP Morgan Chase & Co. (JPM) |
JPM |
STOCK |
Purchase
|
Dec. 27, 2016 |
$$1,001 - $15,000 |
Jan. 29, 2017 |
|
Bill Flores
|
house |
Philip Morris International Inc (PM) |
PM |
STOCK |
New
|
Dec. 21, 2016 |
$$1,001 - $15,000 |
Jan. 17, 2017 |
|
Michael T. McCaul
|
house |
JORDANESE CHASE & CO |
JPM |
STOCK |
SALE
|
Dec. 20, 2016 |
$$1,000,001-$5,000,000 |
Jan. 31, 2017 |
|
Thomas MacArthur
|
house |
Astellas Pharma Inc Unsponsored ADR S (ALPMY) |
ALPMY |
STOCK |
Sale
|
Dec. 7, 2016 |
$$15,001 - $50,000 |
Jan. 7, 2017 |
|
Bill Flores
|
house |
Philip Morris International Inc (PM) |
PM |
STOCK |
Purchase
|
Nov. 29, 2016 |
$$1,001 - $15,000 |
Dec. 11, 2016 |
|
E. Scott Rigell
|
house |
JP Morgan Chase & Co. (JPM) |
JPM |
STOCK |
Purchase
|
Nov. 22, 2016 |
$$15,001 - $50,000 |
Dec. 23, 2016 |
|
Lois Frankel
|
house |
JP Morgan Chase & Co. (JPM) |
JPM |
STOCK |
Sale
|
Nov. 16, 2016 |
$$1,001 - $15,000 |
Dec. 22, 2016 |
|
Bill Flores
|
house |
Philip Morris International Inc (PM) |
PM |
STOCK |
Purchase
|
Nov. 8, 2016 |
$$1,001 - $15,000 |
Dec. 11, 2016 |